[1]
Mocan Hognogi, L.D. and Simiti, L.V. 2016. THE CARDIOVASCULAR IMPACT OF VISFATIN - AN INFLAMMATION PREDICTOR BIOMARKER IN METABOLIC SYNDROME. Medicine and Pharmacy Reports. 89, 3 (Jul. 2016), 322–326. DOI:https://doi.org/10.15386/cjmed-591.